CLEC4F and lung cancer: Histone deacetylase (HDAC) could remove Kcr and Khib in vivo [15, 16], while suberoylanilide hydroxamic acid (SAHA), a HDAC inhibitor, was highly correlated to the change of Kcr and Khib modification in lung cancer cells [17].